| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 23.881 | 24.602 | 25.769 | 32.535 | 40.910 | 45.253 | 45.795 |
| Total Income - EUR | - | - | - | 23.881 | 24.610 | 25.772 | 32.538 | 40.922 | 45.275 | 45.829 |
| Total Expenses - EUR | - | - | - | 6.508 | 7.990 | 5.524 | 13.968 | 18.384 | 17.436 | 27.987 |
| Gross Profit/Loss - EUR | - | - | - | 17.373 | 16.620 | 20.248 | 18.569 | 22.538 | 27.839 | 17.842 |
| Net Profit/Loss - EUR | - | - | - | 17.135 | 16.374 | 19.810 | 18.151 | 22.129 | 27.386 | 15.928 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Bio Psihomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 18.220 | 34.277 | 53.388 | 70.892 | 94.372 | 114.684 | 50.543 |
| Inventories | - | - | - | 0 | 0 | 615 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 3.553 | 4.385 | 5.572 | 3.488 | 8.541 | 7.007 | 6.035 |
| Cash | - | - | - | 14.667 | 29.892 | 47.200 | 67.404 | 85.831 | 107.677 | 44.507 |
| Shareholders Funds | - | - | - | 17.178 | 33.219 | 52.399 | 69.388 | 91.733 | 114.229 | 37.305 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.043 | 1.058 | 988 | 1.503 | 2.639 | 455 | 13.237 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bio Psihomed S.r.l.